IgG-opsonized target cells

IgG-opsonized target cells refer to a biological state where a cell, such as a tumor cell or pathogen, is coated with Immunoglobulin G (IgG) antibodies (Janeway et al., 2001, Immunobiology). This opsonization process is a fundamental mechanism of the humoral immune response, marking the cell for recognition and destruction by innate immune effector cells such as natural killer (NK) cells and macrophages (Weiner et al., 2010, Nature Reviews Cancer). The Fc portion of the bound IgG interacts with Fc gamma receptors (FcγRs) on these effector cells, initiating processes like antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) (Wang et al., 2015, Nature Reviews Immunology). In the context of pharmacology, this state is induced by therapeutic monoclonal antibodies like Rituximab or Trastuzumab to eliminate diseased cells (Scott et al., 2012, Nature Reviews Cancer). The efficiency of this process is highly dependent on factors such as the density of the target antigen, the antibody isotype, and the genetic polymorphisms of the host's Fc receptors (Nimmerjahn & Ravetch, 2008, Nature Reviews Immunology). Because this term describes a cellular complex or state rather than a single protein or gene, it is not considered a discrete molecular therapeutic target in standard pharmacological nomenclature.

Other names

Antibody-coated cellsOpsonized cellsIgG-coated target cellsAntibody-dependent cellular cytotoxicity substrate

Therapeutic monoclonal antibodies bind to specific antigens on the cell surface, forming an IgG-opsonized complex that is recognized by Fc gamma receptors (FcγRs) on effector cells, leading to cell lysis or phagocytosis (Weiner et al., 2010, Nature Reviews Cancer).